3GGA | Hydrolase | date | Feb 27, 2009 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Hiv Protease Inhibitors With Pseudo-Symmetric Cores | ||||||||||||||
authors | V.S.Stoll | ||||||||||||||
compound | source | ||||||||||||||
Molecule: V-1 Protease Chain: G, H, A, B, C, D Engineered: Yes |
Organism_scientific: Human Immunodeficiency Virus 1 Organism_taxid: 11676 Gene: Orf Expression_system: Escherichia Coli Expression_system_taxid: 562 Expression_system_vector_type: Plasmid Expression_system_vector: Pet11b Expression_system_plasmid: Pbs27 | ||||||||||||||
symmetry | Space Group: P 1 21 1 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.50 Å | ||||||||||||
ligand | GGW | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | 2-Pyridyl P1'-substituted symmetry-based human immunodeficiency virus protease inhibitors (A-792611 and A-790742) with potential for convenient dosing and reduced side effects., Degoey DA, Grampovnik DJ, Flentge CA, Flosi WJ, Chen HJ, Yeung CM, Randolph JT, Klein LL, Dekhtyar T, Colletti L, Marsh KC, Stoll V, Mamo M, Morfitt DC, Nguyen B, Schmidt JM, Swanson SJ, Mo H, Kati WM, Molla A, Kempf DJ, J Med Chem. 2009 Apr 23;52(8):2571-86. PMID:19323562 |
Data retrieval |
View 3GGA in 3D |
Visual 3D analysis of 3GGA |
Structure-derived information |
Sequence-derived information |
Other resources with information on 3GGA |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |